Viewing Study NCT06716606


Ignite Creation Date: 2025-12-26 @ 1:19 PM
Ignite Modification Date: 2026-02-25 @ 11:04 PM
Study NCT ID: NCT06716606
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2024-11-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Connective Tissue Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Belimumab View
None Long-term View
None Open label extension View
None Interstitial lung disease View
None Diffuse cutaneous systemic sclerosis View
None Connective tissue disease View